Blood clot prevention medicine recalled over formulation error

A medication that helps prevent blood clots and reduces the risk of heart attacks and strokes has been recalled due to a formulation error. The Medicines and Healthcare products Regulatory Agency (MHRA) said it had been informed by Xeal Pharma that all strengths of its Clopidogrel Oral Suspension and Clopidogrel Oral Solution products contain less...Read moreThe post Blood clot prevention medicine recalled over formulation error appeared first on Nursing in Practice.